FALLOPIAN TUBE CARCINOMA
Clinical trials for FALLOPIAN TUBE CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new FALLOPIAN TUBE CARCINOMA trials appear
Sign up with your email to follow new studies for FALLOPIAN TUBE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Personalized cell therapy takes on Hard-to-Treat ovarian cancer
Disease control Recruiting nowThis study tests a new treatment using specially engineered immune cells (CAR-NK cells) that target two cancer markers at once. It is for people with ovarian, peritoneal, or fallopian tube cancer that has come back or not responded to at least two prior treatments. The therapy is…
Matched conditions: FALLOPIAN TUBE CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Beijing Biotech • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New trick may slash transfusions in ovarian cancer surgery
Disease control Recruiting nowThis study tests a technique called acute normovolemic hemodilution (ANH) during ovarian cancer surgery. Before surgery, some blood is removed and replaced with fluids, then returned later. The goal is to see if this reduces the need for donor blood transfusions. About 86 adults …
Matched conditions: FALLOPIAN TUBE CARCINOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 12, 2026 13:41 UTC
-
New imaging agent could reveal hidden cancers
Diagnosis Recruiting nowThis early-phase study tests a radioactive tracer called [18F]FTT to see if it can help PET/CT scans find more tumor cells in people with solid tumors, including ovarian, breast, and fallopian tube cancers. About 300 participants will receive the tracer and undergo imaging. The g…
Matched conditions: FALLOPIAN TUBE CARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated May 17, 2026 00:45 UTC
-
Home cancer care trial aims to cut travel burden for florida patients
Symptom relief Recruiting nowThis study compares giving cancer treatment at home versus in a clinic for 27 adults with various cancers in the Florida Panhandle. The goal is to see if patients prefer home care and if it is safe. Participants will receive their usual cancer drugs either at home or in the clini…
Matched conditions: FALLOPIAN TUBE CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated May 15, 2026 11:57 UTC
-
New telehealth program aims to ease fatigue in ovarian cancer patients
Symptom relief Recruiting nowThis study tests a supportive telehealth program called REVITALIZE to see if it can reduce how much fatigue interferes with daily life for adults with advanced ovarian cancer who are taking PARP inhibitor maintenance therapy. About 240 participants will either receive the REVITAL…
Matched conditions: FALLOPIAN TUBE CARCINOMA
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Symptom relief
Last updated May 15, 2026 11:55 UTC
-
New study aims to uncover cancer risks in BRCA carriers
Knowledge-focused Recruiting nowThis study follows 600 Japanese women who carry BRCA1 or BRCA2 gene variants to see how often they develop ovarian, fallopian tube, or peritoneal cancers. Researchers will also look at risk factors and check tissue samples for hidden cancers. The goal is to better understand and …
Matched conditions: FALLOPIAN TUBE CARCINOMA
Sponsor: Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan • Aim: Knowledge-focused
Last updated May 12, 2026 13:39 UTC